Indications and Frequency Rate of Permanent Pacemaker Implantation in Elderly Patients
DOI:
https://doi.org/10.70749/ijbr.v2i02.173Keywords:
Cardiac Pacemaker, Complete Heart Block, Sinus Node Disease, Atrioventricular BlockAbstract
Background: Permanent pacemaker has become essential for the treatment of various cardiac diseases nowadays. The process is carried out regularly at the Cardiac Catheterization Laboratory of Hayatabad Medical Complex, Peshawar.
Objective: The purpose of the study was to determine the demographic details, indications, and type of permanent pacemaker implanted in elderly population.
Methods: This was a single-center, prospective study conducted in at Hayatabad Medical Complex, Peshawar from March 2023 to August 2023. During these six months, a total of 218 Patients were included in the study who were regular in their visits to outpatient clinic and had given a written informed permission for participation. Those who did not give a written informed consent for participation were excluded from the study.
Results: Total 218 patients with mean age of 63.4 years range (43-88) undergone Permanent Pacemaker Implantation. Of these 130 (60%) were males. The mean duration of hospital stay was 4.5 days with range (3-7 days). Sinus Node Disease (115 patients, 52.75%) was the most common indication for permanent pacemaker Implantation. Single chamber (VVIR) pacing mode (123 patients, 56.42%) was found to be the most common pacing mode.
Conclusion: Permanent pacemaker implantation has been observed to be common among the elderly population, with a male majority. The most frequent reason for cardiac pacing in older people is sinus node disease, which is followed by atrioventricular block. In Pakistan, due to financial constraints, the single chamber (VVIR) pacing mode is frequently used, followed by the dual chamber (DDDR).
References
Jeffrey K, Parsonnet V. Cardiac pacing, 1960–1985: A quarter century of medical and industrial innovation. Circulation [Internet]. 1998; 97(19):1978–91. Available from: http://dx.doi.org/10.1161/01.cir.97.19.1978
Kotsakou M, Kioumis I, Lazaridis G, Pitsiou G, Lampaki S, Papaiwannou A, et al. Pacemaker insertion. Annals of Translational Medicine [Internet]. 2015 [cited 2024 Aug 22]; 3(3). Available from: http://dx.doi.org/10.3978/j.issn.2305- 5839.2015.02.06
Tsibulko V, Iliev I, Jekova I. A review on pacemakers: Device types, operating modes and pacing pulses. Problems related to the pacing pulses detection [Internet]. Bas.bg. [cited 2024 Aug 22]. Available from: https://www.biomed.bas.bg/bioautomation/2014/vol_18.2/files/18.2_03.pdf
Wood MA, Ellenbogen KA. Cardiac pacemakers from the patient’s perspective. Circulation [Internet]. 2002; 105(18):2136–8. Available from: http://dx.doi.org/10.1161/01.cir.0000016183.07898.90
Weisz G, Olszynko-Gryn J. The theory of epidemiologic transition: The origins of a citation classic. J Hist Med Allied Sci [Internet]. 2010; 65(3):287–326. Available from: http://dx.doi.org/10.1093/jhmas/jrp058
Reddy KS, Yusuf S. Emerging epidemic of cardiovascular disease in developing countries. Circulation [Internet]. 1998; 97(6):596–601. Available from: http://dx.doi.org/10.1161/01.cir.97.6.596
Zhan C, Baine WB, Sedrakyan A, Steiner C. Cardiac device implantation in the United States from 1997 through 2004: A population-based analysis. J Gen Intern Med [Internet]. 2008; 23(S1):13–9. Available from: http://dx.doi.org/10.1007/s11606-007-0392-0
Baddour LM, Epstein AE, Erickson CC, Knight BP, Levison ME, Lockhart PB, et al. Update on cardiovascular implantable electronic device infections and their management: A scientific statement from the American Heart Association. Circulation [Internet]. 2010; 121(3):458–77. Available from: http://dx.doi.org/10.1161/circulationaha.109.192665
Authors/Task Force Members, Vardas PE, Auricchio A, Blanc J-J, Daubert J-C, Drexler H, et al. Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in Collaboration with the European Heart Rhythm Association. Eur Heart J [Internet]. 2007; 28(18):2256–95. Available from: https://secardiologia.es/images/stories/secciones/estimulacion/guias-clinicas/guias- de-marcapasos-y-resincronizacion-de-la-esc-2007.pdf
Uslan DZ, Tleyjeh IM, Baddour LM, Friedman PA, Jenkins SM, St Sauver JL, et al. Temporal trends in permanent pacemaker implantation: A population- based study. Am Heart J [Internet]. 2008; 155(5):896–903. Available from: http://dx.doi.org/10.1016/j.ahj.2007.12.022
Eltrafi A, Currie P, Silas JH. Permanent pacemaker insertion in a district general hospital: indications, patient characteristics, and complications. Postgrad Med J [Internet]. 2000 [cited 2024 Aug 22];76(896):337–9. Available from: https://academic.oup.com/pmj/article-abstract/76/896/337/7040095
Harrigan RA, Chan TC, Moonblatt S, Vilke GM, Ufberg JW. Temporary transvenous pacemaker placement in the Emergency Department. J Emerg Med [Internet]. 2007;32(1):105–11. Available from: http://dx.doi.org/10.1016/j.jemermed.2006.05.03
Mond HG, Proclemer A. The 11th world survey of cardiac pacing and implantable cardioverter‐ defibrillators: calendar year 2009-a World Society of Arrhythmia's project. Pacing Clin Electrophysiol. 2011; 34: 1013-27.
Andersen HR, Thuesen L, Bagger JP, Vesterlund T, Thomsen PEB. Prospective randomised trial of atrial versus ventricular pacing in sick-sinus syndrome. The Lancet. 1994; 344: 1523-28.
Andersen HR, Nielsen JC, Thomsen PEB, Thuesen L, Mortensen PT, Vesterlund T, et al. Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome. The Lancet. 1997; 350: 1210-16
Belott PH. A variation on the introducer technique for unlimited access to the subclavian vein. Pacing and Clinical Electrophysiology. 1981; 4: 43-7.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Indus Journal of Bioscience Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
